RIGL Related Analyst Ratings

Nov 23, 2009 08:28 AM RBC Upgrades Rigel Pharmaceuticals (RIGL) to Outperform

Jul 24, 2009 09:11 AM Citi Downgrades Rigel Pharmaceuticals (RIGL) to Hold

Jul 10, 2009 09:32 AM Boenning & Scattergood Upgrades Rigel Pharmaceuticals (RIGL) to Outperform

Jun 9, 2009 02:11 PM Rodman & Renshaw Starts Rigel Pharma (RIGL) at Market Outperform, Multi-Billion Drug Potential

May 20, 2009 01:12 PM Barclays Gets Bullish On US Biotechnology Sector (BBH)

May 6, 2009 08:45 AM RBC Upgrades Rigel Pharmaceuticals (RIGL) to Sector Perform

Jan 30, 2009 08:11 AM RBC Capital Downgrades Rigel Pharmaceuticals (RIGL) to Underperform

Dec 16, 2008 01:53 PM Collins Stewart Initiates Coverage on Rigel Pharmaceuticals (RIGL) with a Hold

Oct 28, 2008 09:00 AM Susquehanna Reiterates a Positive on Rigel Pharmaceuticals (RIGL), Lowers Price Target

Oct 28, 2008 08:59 AM RBC Downgrades Rigel Pharma (RIGL) to Sector Perform

Oct 21, 2008 11:29 AM Susquehanna Initiates Coverage on Rigel Pharmaceuticals (RIGL) with a Positive

Oct 1, 2008 10:44 AM Piper Jaffray Initiates Coverage on Rigel Pharmaceuticals (RIGL) with a Buy

Sep 3, 2008 08:57 AM RBC Capital Initiates Coverage on Rigel Pharmaceuticals (RIGL) with an Outperform

Aug 27, 2008 07:50 AM Citi Initiates Coverage on Rigel (RIGL) with a Buy

Jul 22, 2008 08:22 AM Stanford Group Initiates Coverage on Rigel Pharmaceuticals (RIGL) with a Buy

Dec 14, 2007 07:11 AM Lehman Bros. Upgrades Rigel Pharmaceuticals (RIGL) to Overweight

Oct 24, 2007 08:51 AM CIBC Starts Rigel Pharmaceuticals (RIGL) with a Sector Outperformer

Jul 19, 2007 08:41 AM Credit Suisse Starts Rigel Pharms (RIGL) at Outperform

Jun 8, 2007 09:20 AM Jefferies & Co Initiates Coverage on Rigel Pharmaceuticals (RIGL) with a Buy

Dec 5, 2006 01:48 PM Needham Highlights Biotech Companies Presenting at the Upcoming American Society of Hematology

Dec 1, 2005 08:25 AM CSFB downgrades RIGL to Neutral

Sep 22, 2005 07:25 AM Wachovia Starts RIGL at Outperform

Jul 1, 2005 08:06 AM JMP Securities Started RIGL at Market Outperform